InvestorsHub Logo
Followers 0
Posts 456
Boards Moderated 0
Alias Born 09/26/2009

Re: skyticket1 post# 6734

Tuesday, 07/29/2014 11:55:59 AM

Tuesday, July 29, 2014 11:55:59 AM

Post# of 8299
I don't think it's coincidence he registered the number of shares he did when he did. I'm quite sure he is privy to ALOT more info than we are. His primary interest was in the potential of all the applications of Oxycyte. I'm quite sure the ARMY and NAVY won't be happy with today's conference call. The guy that came on last was grilling Kelley pretty good (thankfully) and kept pressing for an answer. You could tell by the demeanor of the replies that management has no interest in pursuing Oxycyte presently or maybe ever. I'm not saying that LEVO isn't a very valuable drug and probably has a lot more data available than most drugs, but I was viewing this as a one two punch company. Get LEVO approved and then expand Oxycyte which was my main focus as well. That seems to be off the table now. I will certainly hold the shares I have and wait for better prices, but I'm not sure this will be the long term hold I thought it was. In other words, today's call took the wind out of my sails.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TENX News